CIK 0000872912 · Non-accelerated filer<br>Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061245881
- Phone
- (518) 743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $488,508
- in 1 filing
Net −$488,508. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-23 | SALAMON STEVEN A J Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2024-05-23 | Aharon Gil Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2024-05-23 | Martell Bridget A Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Returned to the company · Stock Option (Right to Buy) | −142 | 0 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Grant or award · Stock Option (Right to Buy) | +142 | 142 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Returned to the company · Stock Option (Right to Buy) | −9,000 | 0 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Returned to the company · Stock Option (Right to Buy) | −9,000 | 0 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Returned to the company · Stock Option (Right to Buy) | −19,682 | 0 | ||
| 2024-05-23 | STOLL ROGER G PHD Director | Grant or award · Stock Option (Right to Buy) | +19,682 | 19,682 | ||
| 2024-04-18 | Aharon Gil Director | Option exercise | +619,946 | $0.01 | $6K | 2,681,271 |
| 2024-04-18 | Aharon Gil Director | Conversion | +991,615 | 2,681,271 | ||
| 2024-04-18 | Aharon Gil Director | Option exercise | +619,946 | $6,199.46 | $3.8B | 2,681,271 |
| 2024-04-18 | Aharon Gil Director | Conversion | +991,615 | 2,681,271 | ||
| 2024-04-18 | SALAMON STEVEN A J Director | Option exercise | +619,946 | $0.01 | $6K | 2,732,586 |
| 2024-04-18 | SALAMON STEVEN A J Director | Conversion | +991,615 | 2,732,586 | ||
| 2024-04-18 | SALAMON STEVEN A J Director | Conversion | +991,615 | 2,732,586 |
Page 4 of 7 · 138 trades